OMX Stockholm Pharmaceuticals a SX201030GI Indice
6888.13 SEK
{{ price }}
0.270826%
{{change_pct}}%
PAESE
stati Uniti
Borsa valori
Nasdaq GIDS
MIN - MAX [24 ore]
6888.13
-
6888.13 SEK
Numero di componenti
32
OMX Stockholm Pharmaceuticals a Grafico dei prezzi
Top 5 Vincitori delle Ultime 24 Ore
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | +7.14% | |
|---|---|---|---|
| VICO.ST | Vicore Pharma Holding AB (publ) | +7.13% | |
| ISOFOL.ST | Isofol Medical AB (publ) | +4.79% | |
| XBRANE.ST | Xbrane Biopharma AB (publ) | +2.74% | |
| ORX.ST | Orexo AB (publ) | +2.25% |
Top 5 Perdenti delle Ultime 24 Ore
| HNSA.ST | Hansa Biopharma AB (publ) | -7.48% | |
|---|---|---|---|
| BONEX.ST | Bonesupport Holding AB (publ) | -5.8% | |
| ATORX.ST | Alligator Bioscience AB (publ) | -5.19% | |
| XSPRAY.ST | Xspray Pharma AB (publ) | -4.14% | |
| SANION.ST | Saniona AB (publ) | -3.13% |
OMX Stockholm Pharmaceuticals a SX201030GI PANORAMICA FINANZIARIA E DI TRADING
| OMX Stockholm Pharmaceuticals a Prezzo dell'Indice | 6888.13 SEK |
| Chiusura Precedente | N/A |
| Apertura | N/A |
| Prezzo di Acquisto | N/A x N/A |
| Prezzo di Vendita | N/A x N/A |
| Variazione Giornaliera | N/A |
| Variazione a 52 Settimane | N/A |
| Volume | N/A |
| Volume Medio | N/A |
Informazioni di trading
OMX Stockholm Pharmaceuticals a Storico dei prezzi dell'Indice
| Massimo a 52 Settimane | N/A |
| Minimo a 52 Settimane | N/A |
| Media Mobile a 50 Giorni | N/A |
| Media Mobile a 200 Giorni | N/A |
SX201030GI Statistiche dell'indice
| Volume Medio (3 Mesi) | N/A |
| Vol. Medio Giornaliero (10 Giorni) | N/A |
D&R per l'Indice OMX Stockholm Pharmaceuticals a
Qual è il prezzo attuale dell'Indice SX201030GI?
Il prezzo dell'Indice OMX Stockholm Pharmaceuticals a SX201030GI oggi è di 6888.13 SEK.
Come acquistare l'Indice OMX Stockholm Pharmaceuticals a?
Puoi acquistare l'indice SX201030GI sulla borsa Nasdaq GIDS. Contatta il tuo consulente finanziario per selezionare un broker.
Qual è la sigla borsistica dell'Indice OMX Stockholm Pharmaceuticals a?
La sigla (o ticker) dell'Indice OMX Stockholm Pharmaceuticals a è SX201030GI.
Quanti componenti contiene l'Indice OMX Stockholm Pharmaceuticals a?
L'Indice OMX Stockholm Pharmaceuticals a contiene 32 componenti.
A quale paese appartiene l'Indice OMX Stockholm Pharmaceuticals a?
L'Indice OMX Stockholm Pharmaceuticals a fa riferimento a United States.
A quale borsa appartiene l'Indice OMX Stockholm Pharmaceuticals a?
L'Indice OMX Stockholm Pharmaceuticals a fa riferimento alla borsa Nasdaq GIDS.
OMX Stockholm Pharmaceuticals a COMPONENTI
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
|---|
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Swedish Orphan Biovitrum AB (publ) SOBI.ST | $279.2 27.25 USD |
+0.58
|
$95.89B 9.36B USD | $304.52K 29.72K USD | $274.4 26.78 USD | $280.4 27.37 USD | $95.89B 9.36B USD | 24.83 | $11.24 1.1 USD |
| Camurus AB (publ) CAMX.ST | $590 57.59 USD |
+0.17
|
$34.74B 3.39B USD | $37.21K 3.63K USD | $576 56.22 USD | $592 57.79 USD | $34.74B 3.39B USD | 82.05 | $7.19 0.7 USD |
| Bonesupport Holding AB (publ) BONEX.ST | $299 29.19 USD |
-5.8
|
$19.69B 1.92B USD | $409.29K 39.95K USD | $296 28.89 USD | $307.8 30.05 USD | $19.69B 1.92B USD | 162.50 | $1.84 0.18 USD |
| BioArctic AB (publ) BIOA-B.ST | $185.4 18.1 USD |
-2.01
|
$16.06B 1.57B USD | $175.29K 17.11K USD | $184.3 17.99 USD | $191.3 18.67 USD | $16.06B 1.57B USD | 0 | -$2.01 -0.1 USD |
| Biotage AB (publ) BIOT.ST | $140.7 13.73 USD |
+0.07
|
$11.34B 1.11B USD | $955.92K 93.31K USD | $140.6 13.72 USD | $141.6 13.82 USD | $11.34B 1.11B USD | 44.24 | $3.18 0.31 USD |
| Calliditas Therapeutics AB (publ) CALTX.ST | $208 20.3 USD |
0
|
$11.24B 1.1B USD | $0 0 USD | $0 0 USD | $0 0 USD | $11.24B 1.1B USD | 0 | $0 0 USD |
| BioGaia AB (publ) BIOG-B.ST | $100.3 9.79 USD |
-0.69
|
$10.12B 987.49M USD | $93.9K 9.17K USD | $100.3 9.79 USD | $102.7 10.02 USD | $10.12B 987.49M USD | 28.82 | $3.48 0.34 USD |
| MedCap AB (publ) MCAP.ST | $414 40.41 USD |
-0.36
|
$6.2B 605.42M USD | $26.44K 2.58K USD | $412 40.22 USD | $422 41.19 USD | $6.2B 605.42M USD | 29.57 | $14 1.37 USD |
| Probi AB (publ) PROB.ST | $348 33.97 USD |
0
|
$3.97B 387.05M USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.97B 387.05M USD | 0 | $0 0 USD |
| BioInvent International AB (publ) BINV.ST | $29.3 2.86 USD |
0
|
$1.94B 189.49M USD | $33.48K 3.27K USD | $28.9 2.82 USD | $29.55 2.88 USD | $1.94B 189.49M USD | 0 | -$6.53 -0.6 USD |
| Vicore Pharma Holding AB (publ) VICO.ST | $7.96 0.78 USD |
+7.13
|
$1.91B 186.19M USD | $473.9K 46.26K USD | $7.32 0.71 USD | $8.09 0.79 USD | $1.91B 186.19M USD | 0 | -$1.23 -0.1 USD |
| Hansa Biopharma AB (publ) HNSA.ST | $26.24 2.56 USD |
-7.48
|
$1.72B 168.05M USD | $345.07K 33.68K USD | $26.22 2.56 USD | $28.5 2.78 USD | $1.72B 168.05M USD | 0 | -$9.25 -0.9 USD |
| Egetis Therapeutics AB (publ) EGTX.ST | $3.92 0.38 USD |
-1.26
|
$1.41B 137.46M USD | $233.21K 22.76K USD | $3.87 0.38 USD | $4.05 0.39 USD | $1.41B 137.46M USD | 0 | -$1.1 -0.1 USD |
| Xspray Pharma AB (publ) XSPRAY.ST | $33.55 3.27 USD |
-4.14
|
$1.32B 128.75M USD | $34.31K 3.35K USD | $32.15 3.14 USD | $38 3.71 USD | $1.32B 128.75M USD | 0 | -$8.62 -0.8 USD |
| SynAct Pharma AB SYNACT.ST | $19.94 1.95 USD |
-0.1
|
$977.24M 95.39M USD | $113.89K 11.12K USD | $19.24 1.88 USD | $20.5 2 USD | $977.24M 95.39M USD | 0 | -$2.08 -0.2 USD |
| Saniona AB (publ) SANION.ST | $7.12 0.7 USD |
-3.13
|
$968.95M 94.58M USD | $270.34K 26.39K USD | $7.01 0.68 USD | $7.33 0.72 USD | $968.95M 94.58M USD | 4.04 | $1.76 0.17 USD |
| Infant Bacterial Therapeutics AB (publ) IBT-B.ST | $57 5.56 USD |
+7.14
|
$772.2M 75.38M USD | $31.56K 3.08K USD | $52.5 5.12 USD | $59.3 5.79 USD | $772.2M 75.38M USD | 0 | -$10.16 -0.9 USD |
| Abliva AB (publ) ABLI.ST | $0.44 0.04 USD |
0
|
$715.67M 69.86M USD | $0 0 USD | $0 0 USD | $0 0 USD | $715.67M 69.86M USD | 0 | $0 0 USD |
| Orexo AB (publ) ORX.ST | $14.52 1.42 USD |
+2.25
|
$502.43M 49.04M USD | $6.04K 589.77 USD | $13.88 1.35 USD | $14.94 1.46 USD | $502.43M 49.04M USD | 0 | -$5.89 -0.5 USD |
| Oncopeptides AB (publ) ONCO.ST | $1.94 0.19 USD |
+0.31
|
$410.7M 40.09M USD | $184.13K 17.97K USD | $1.93 0.19 USD | $2 0.2 USD | $410.7M 40.09M USD | 0 | -$1.71 -0.1 USD |
- {{ link.label }} {{link}}